InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-46.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by OrbiMed Israel BioFund GP Limited Partnership. Officer active across 1 company, notably BiomX Inc.. Aggregated, 3 filings have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €81k. History available since 27 February 2023. The latest transaction was filed on 15 May 2024 (X). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to OrbiMed Israel BioFund GP Limited Partnership
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
9,280,408 股@ US$0.24496.3% 占其流量Common StockSEC:0000947871-24-000498:0
348,000 股@ US$0.2453.7% 占其流量Common StockSEC:0000947871-23-000336:0
标准退出：2023年5月28日 (T+90)
500,000 股Common Stock, $0.0001 par valueSEC:0000947871-21-000844:0
标准退出：2021年10月26日 (T+90)
3 条申报中的 3 条
About OrbiMed Israel BioFund GP Limited Partnership
OrbiMed Israel BioFund GP Limited Partnership is a declarant linked to BiomX Inc. (XNAS). The declarant has 4 filings in total, and within the 4 recent filings held, buys total 80779 EUR and sells total 0 EUR, over the period from 2021-07-30 to 2024-05-20. The modal transaction nature is Acquisition.
